Bioventus (BVS) EV to EBITDA (2021 - 2026)

Bioventus (BVS) EV to EBITDA (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBITDA
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	18.98
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	23.38
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	15.68
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	18.06
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	33.83
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	10.45
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.00
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	26.94
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	18.04
10	Bioventus	571.68 Mn	581.20 Mn	90.77 Mn	16.96

Download Data